Abstract
Healthcare has played a main role in the Semantic Web (SW) field given the knowledge representation possibilities that SW is capable of addressing. Nowadays there are a large number of ontologies which can be used for several domains of healthcare (genetics, proteins, cellular components, anatomy, and specific diseases among others). However, in some cases, the definition and population of these ontologies are not enough to be used in concrete domains. In this paper we provide the design of a set of ontologies for their direct use in diagnostic decision support systems. We have designed an ontology modular architecture where main (root) ontology is created to define the main relations which can be found in the aforementioned domain. A set of subsumed ontologies has also been designed following some principles of OBO-Foundry and using SNOMED-CT terminology as the main interoperability component. These ontologies have been also designed trying to create them as light as possible. The evaluation of the designed ontology is based on a set of quantitative aspects which aims to show the main principles which should be followed in the process of design ontologies for the domain of differential diagnosis.
Keywords: Knowledge representation, medical diagnosis, ontology, Semantic web, Healthcare, in diagnostic decision support systems, OBO-Foundry, SNOMED-CT, DDxOnt, Interoperability Database.
Current Bioinformatics
Title:Towards an Ontology to Support Semantics Enabled Diagnostic Decision Support Systems
Volume: 7 Issue: 3
Author(s): Alejandro Rodriguez-Gonzalez, Gandhi Hernandez-Chan, Ricardo Colomo-Palacios, Juan Miguel Gomez-Berbis, Angel Garcia-Crespo, Giner Alor-Hernandez and Rafael Valencia-Garcia
Affiliation:
Keywords: Knowledge representation, medical diagnosis, ontology, Semantic web, Healthcare, in diagnostic decision support systems, OBO-Foundry, SNOMED-CT, DDxOnt, Interoperability Database.
Abstract: Healthcare has played a main role in the Semantic Web (SW) field given the knowledge representation possibilities that SW is capable of addressing. Nowadays there are a large number of ontologies which can be used for several domains of healthcare (genetics, proteins, cellular components, anatomy, and specific diseases among others). However, in some cases, the definition and population of these ontologies are not enough to be used in concrete domains. In this paper we provide the design of a set of ontologies for their direct use in diagnostic decision support systems. We have designed an ontology modular architecture where main (root) ontology is created to define the main relations which can be found in the aforementioned domain. A set of subsumed ontologies has also been designed following some principles of OBO-Foundry and using SNOMED-CT terminology as the main interoperability component. These ontologies have been also designed trying to create them as light as possible. The evaluation of the designed ontology is based on a set of quantitative aspects which aims to show the main principles which should be followed in the process of design ontologies for the domain of differential diagnosis.
Export Options
About this article
Cite this article as:
Rodriguez-Gonzalez Alejandro, Hernandez-Chan Gandhi, Colomo-Palacios Ricardo, Miguel Gomez-Berbis Juan, Garcia-Crespo Angel, Alor-Hernandez Giner and Valencia-Garcia Rafael, Towards an Ontology to Support Semantics Enabled Diagnostic Decision Support Systems, Current Bioinformatics 2012; 7 (3) . https://dx.doi.org/10.2174/157489312802460721
DOI https://dx.doi.org/10.2174/157489312802460721 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Interventional Pulmonologist’s Tool: Endobronchial Ultrasound- Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Thoracic Disease — An Update
Current Respiratory Medicine Reviews Clinical Implications of Methotrexate Pharmacogenetics in Childhood Acute Lymphoblastic Leukaemia
Current Drug Metabolism New Technologies in Male Contraception
Current Women`s Health Reviews Antifungal Therapy of Aspergillosis of the Central Nervous System and Aspergillus Endophthalmitis
Current Pharmaceutical Design Genomics and Proteomics of Nucleoside Transporters
Current Pharmacogenomics Perspective of MiRNAs in Clinical Glioblastoma Research
Current Signal Transduction Therapy Phytochemistry and Pharmacognosy of Naturally Occurring Prenyloxyanthraquinones
Current Drug Targets Recent Advances in the Use of Metallic Nanoparticles with Antitumoral Action - Review
Current Medicinal Chemistry Hippocampal Neurogenesis, Neurotrophic Factors and Depression: Possible Therapeutic Targets?
CNS & Neurological Disorders - Drug Targets Upregulation of Focal Adhesion Kinase by 14-3-3ε via NFκB Activation in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Novel Approaches for RNA Interference and their Application in Cancer Therapy
Current Pharmacogenomics Diagnostic and Prognostic Potential of the Macrophage Specific Receptor CD163 in Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) “Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems
Drug Delivery Letters The Role of Autophagy in the Gut Pathogens Clearance and Evasion
Current Protein & Peptide Science The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice
Current Molecular Medicine Evaluating Potential P-gp Substrates: Main Aspects to Choose the Adequate Permeability Model for Assessing Gastrointestinal Drug Absorption
Mini-Reviews in Medicinal Chemistry Random Mutagenesis Methods for In Vitro Directed Enzyme Evolution
Current Protein & Peptide Science Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy
Current Drug Metabolism HOX Genes as Potential Markers of Circulating Tumour Cells
Current Molecular Medicine Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents
Current Medicinal Chemistry